FDA Approves First Molecular-Based Lab Test To Detect Metastatic Breast Cancer

 

The U.S. Food and Drug Administration has approved the first molecular-based laboratory test for detecting whether breast cancer has spread (metastasized) to nearby lymph nodes. The GeneSearch BLN Assay detects molecules that are abundant in breast tissue but scarce in a normal lymph node.
The presence or absence of breast cancer cells in underarm lymph nodes is a powerful predictor of whether the cancer has spread and is used to help decide appropriate therapy for a woman with metastatic breast cancer.

FDA Approves First Molecular-Based Lab Test To Detect Metastatic Breast Cancer